Vicki Sato is professor of management practice at Harvard Business School, and also professor of the practice in the department of molecular and cell biology at Harvard University. Vicki is a business advisor to Atlas, as well as other enterprises in biotech and pharma.
Dr. Sato retired from Vertex Pharmaceuticals, where she served as president since 2000, with responsibility for research and development, business and corporate development, commercial operations, legal, and finance. Prior to this role, she was chief scientific officer, senior vice president of research and development, and chair of the scientific advisory board. Under her leadership, Vertex created a diversified pipeline of drugs, including two HIV protease inhibitors approved and marketed by GlaxoSmithKline, an oral protease inhibitor (VX 950) for the treatment of hepatitis C, two anti-inflammatory drug candidates, a novel molecule for the treatment of cystic fibrosis, and two kinase inhibitors in development with Novartis and Merck for the treatment of cancers. In addition, a new molecule for the management of pain has been recently licensed to GlaxoSmithKline.
Before joining Vertex, Dr. Sato worked in executive management as vice president of research at Biogen, Inc, where she led research programs in the areas of inflammation, thrombosis, and HIV disease. Several molecules from those programs have now reached the marketplace. She also served as a member of Biogen’s Scientific Board.
Currently, Dr. Sato serves on the board of Bristol Myers Squibb Company, PerkinElmer Corporation, Infinity Pharmaceuticals, Alnylam Pharmaceuticals, and Atlas Venture portfolio company Avila Therapeutics. She is also a trustee of Jose Mateo’s Ballet Theatre, chair of the overseers of the Isabella Stewart Gardner Museum, and an advisor to the Accelerated Cure Project, a nonprofit organization committed to finding a cure for multiple sclerosis.
Dr. Sato received an AB from Radcliffe College, and an AM and PhD from Harvard University. Following postdoctoral work at both the University of California Berkeley and Stanford Medical Center, Dr. Sato was appointed to the faculty of Harvard University, where she was an assistant and associate professor of biology.